Cannabis Market is Projected to Grow Exponentially

The cannabis industry is growing at an exponential pace due to the recent string of countries and U.S. states legalizing cannabis. However, the industry still remains in its infancy stage, considering only two countries have completely legalized it. Uruguay became the first country ever to fully legalize cannabis entirely back in 2013 when its former President Jose Mujica signed the legislation. Half a decade later, Canada followed Uruguay and legalized cannabis entirely as well.

There are several countries that maintain very lenient regulations when it comes to cannabis, but technically, it is still not legalized. The Netherlands allows citizens to keep and cultivate some marijuana. Coffee shops are permitted to sell marijuana as long as it’s not to minors. Similarly, Spain also has shops and clubs where people are allowed to use cannabis, however, it still illegal to sell. Despite countries like the Netherlands and Spain having relaxed rules regarding cannabis, the U.S. is still projected to dominate the industry even though it is still not federally legalized.

U.S. states began to legalize cannabis for medical applications as early as the 1990s. Currently, 33 states and the District of Columbia have legalized cannabis on a certain level. Among the 33, Alaska, California, Colorado, Maine, Massachusetts, Michigan, Nevada, Oregon, Vermont and Washington have legalized cannabis for recreational usage. Colorado and Washington became the first when voters passed the ballot back in 2012 to legalize recreational use. Now, states like California, Colorado, Washington, and Nevada are already or expected to drive in over a billion dollars in revenue annually, accounting for majority of the broad cannabis market value.

Based on recent trends, data compiled by Arcview Market Research in partnership with BDS Analytics predicts that worldwide consumer spending on legal cannabis will reach USD 57 Billion by 2027. The research also forecasts that adult-use cannabis will makeup majority of the spending totaling USD 38.3 Billion, while medical spending is expected to reach USD 19.1 Billion. The North American segment is expected to account for the largest spending volume, growing from USD 9.2 Billion in 2017 to USD 47.3 Billion in 2027. However, the research also suggests that Europe has potential to hold the largest medical cannabis spending.

CLS Holdings USA, Inc. (OTCQB: CLSH) (CSE: CLSH) has captured the opportunity by expanding itself within the U.S. market. Originally, CLS started in Nevada and acquired Oasis Cannabis Dispensary. Oasis operates a dispensary in Las Vegas, Nevada. CLS expanded itself into Massachusetts recently with the acquisition of In Good Health, Inc. In Good Health operates a medical dispensary just south of Boston and is one of the 48 licensed dispensaries in the state.

Massachusetts is a much smaller cannabis market compared to states like Colorado. Colorado has over 500 licensed dispensaries and over 700 licensed cultivation facilities. While Massachusett is rather small compared to other states that are already booming in sales, however, it is among the few states that have legalized cannabis for recreational usage. Despite its market size, Massachusetts is still developing and could position itself to be a major growth driver for the overall industry.

Continued growth in the maturing medical and recreational segment, ongoing legalization efforts globally, and developing research and development of cannabis itself is expected to propel the industry. Investments into the market are steadily pouring in, allowing cannabis to potentially become the next global industry phenomenon. “The industry is at about 5 percent of what it will be someday,” concurs Tyler Stratford, Director of Client Operations for cannabis consulting firm Canna Advisors. “Even if the path forward isn’t straight, we’re certainly on a path forward. The tide has changed, and there’s no turning it back now.”

Sponsored Content Release. Click for Full Disclosure

  1. Gregory Lee 7 months ago

    the recreational market for cannabis will grow much faster than medical. Medical will always have a market and demand but the exponential growth is definitely going to grow faster with the ongoing pursuit of legalization worldwide

    • Peter Williams 7 months ago

      I believe the medical market has the customer base already. The recreational cannabis size will grow as more consumers venture from illegal cannabis to legal cannabis

Leave a Comment

  • Sponsored Content Release, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, creates 100% unique original content. also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

    Please Note: is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on (the ‘Site’) is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content),, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. receives fees for producing and presenting high quality and sophisticated content on along with other financial news PR media services. does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along with financial and corporate news. only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For cls holdings usa inc. financial and corporate news dissemination, has been compensated five thousand dollars by the company. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. will always disclose any compensation in securities or cash payments for financial news PR advertising. does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security., members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: